人物經歷
1978-1982: 上海第二醫科大學學士學位 1985-1988: 上海第二醫科大學碩士學位 1989-1990: 澳大利亞皇家北岸醫院風濕病學科訪問學者
著作譯作
1. Pachydermodactyly: Six New Cases From China。葉霜、鮑春德等。Journal of Clinical Rheumatolgy 2005;11(2):72-75。SCI收錄 2. 血清中6-磷酸葡萄糖異構酶抗原升高在類風濕關節炎中的意義探討。鮑春德、葉萍等。中華風濕病學雜誌 2005;9(5):277-280。核心期刊 3. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial。Lü Liang-jing, TENG Jia-lin, BAO Chun-de, HAN Xing-hai, SUN Ling-yun, XU Jiang-hua, LI Xing-fu and WU Hua-xiang。Chinese Medical Journal 2008; 121(7):615-619 4. Glycogen storage disease manifested as gout and myopathy: three case reports and literature review。Wei Zhang & Chun-de Bao & Yue-ying Gu & Shuang Ye。Clin Rheumatol (2008) 27:671–674 5. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients。Qiong Fu *, Xiaoqing Chen *, Huijuan Cui , Yanzhi Guo , Jing Chen , Nan Shen * and Chunde Bao。Arthritis Research & Therapy 2008, 10(5):R112 6. T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis。Fang Du, Liang-jing Lü, Qiong Fu, Min Dai, Jia-lin Teng, Wei Fan, Shun-le Chen, Ping Ye, Nan Shen, Xin-fang Huang, Jie Qian and Chun-de Bao。Arthritis Research & Therapy 2008, 10(6):R136 7. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China。Dawei Hu • Chunde Bao • Shunle Chen • Jieruo Gu • Zhanguo Li • Lingyun Sun • Xinghai Han • Liqing Ni。Rheumatol Int (2009) 29:297–303 8. Evaluation of Risk Factors That Contribute to High Prevalence of Premature Atherosclerosis in Chinese Premenopausal Systemic Lupus Erythematosus Patients。Chun-Yan Zhang, MD,* Liang-Jing Lu, PhD,* Feng-Hua Li, MD,+ Hong-Li Li, PhD,+ Yue-Ying Gu, MD,* Shun-le Chen, MD,* and Chun-De Bao, PhD*。JCR: Journal of Clinical Rheumatology * Volume 15, Number 3, 111-116,April 2009 9. Multicenter, Randomized, Double-Blind, Controlled Trial of Treatment of Active Rheumatoid Arthritis With T-614 Compared With Methotrexate。LIANG-JING LU, CHUN-DE BAO, MIN DAI, JIA-LIN TENG, WEI FAN, FANG DU, NAN-PING YANG, YIN-HUAN ZHAO, ZHI-WEI CHEN, JIAN-HUA XU, PEI-GEN HE, HUA-XIANG WU, YI TAO, MIAO-JIA ZHANG, XING-HAI HAN, XING-FU LI, JIE-RUO GU, JIAN-HUA LI, AND HAO YU。Arthritis & Rheumatism (Arthritis Care & Research) Vol. 61, No. 7, July 15, 2009, pp 979–987 10. Interferon-αPriming promotes lipid uptake and macrophage-derived foam cell formation: A novel link between interferon-αand atherosclerosis in Lupus. Jia Li, Qiong Fu, Huijuan Cui, Bo Qu, Wen Pan, Nan Shen, and Chunde Bao. P488-492, Arthritis & Rheumatism Volume 63, Number 2, February 2011 11. 狼瘡腎炎患者血清白細胞介素-18的升高與Th1/Th2型細胞的失衡。通訊作者。中華風濕病學雜誌2007;11(3):158-161。 12. 神經精神狼瘡預後相關因素的臨床分析。通訊作者。中華風濕病學雜誌2007;11(8):482-485 13. 系統性紅斑狼瘡與早發動脈粥樣硬化及其相關危險因素。通訊作者。中華風濕病學雜誌2007;11(8):458-461 14. 艾拉莫德治療類風濕關節炎多中心 隨機 雙盲 安慰劑對照研究。通訊作者。中華風濕病學雜誌2007;11(8):462-465 15. 以痛風 肌炎為臨床表現的糖原累積症三例及文獻複習。通訊作者。中華風濕病學雜誌2007;11(9):535-537 16. 老年系統性紅斑狼瘡診治進展。第一作者。實用老年醫學。2008;22(1):17-20 17. 骨橋蛋白與自身免疫性疾病。第一作者。中華風濕病學雜誌2008;12(4):217-218 18. 無症狀高肌酸激酶血症的診斷。通訊作者。中華風濕病學雜誌2008;12(4):274-277 19. 腫瘤壞死因子拮抗劑治療類風濕關節炎的安全性評價。第一作者。臨床藥物治療雜誌2008;6(4):17-23 20. 英夫利西單抗治療類風濕關節炎、強直性脊柱炎與克羅恩病。第一作者。中國新藥與臨床雜誌2008;27(3):233-236 21. 趨化因子積分是系統性紅斑狼瘡活動和損傷的生物標誌物。通訊作者。中華風濕病學雜誌2008;12(12):803-807 22. 提高抗中性粒細胞胞漿抗體相關性血管炎的診治水平。第一作者。上海醫學2008;31(12):837-840 23. 重視系統性紅斑狼瘡合併感染的診治。第一作者。中華風濕病學雜誌2009;13(3):145-147 24. 風濕病疑難問答。鮑春德。 人民衛生出版社。2004。參考書
獲獎情況
獲國家科技進步二等獎,上海市科技進步一等獎,衛生部科技進步獎等多項獎項
學術任職
曾擔任上海風濕病學會主任委員、中華風濕病學會第6,7屆副主任委員、中國醫師學會風濕病學分會第1,2屆副會長。現任中華風濕病學會常委,中國醫師協會風濕病分會常委;上海市醫師協會風濕免疫科醫師分會首任會長,《中華風濕病學》雜誌副總編和《中華變態反應—臨床免疫》雜誌常務編委。
擅長領域
重症狼瘡、難治性類風濕性關節炎、無肌炎皮肌炎伴重症間質性肺炎及ANCA相關血管炎診治方面,解決風濕病疑難重症
系統性紅斑狼瘡等風濕性疾病的臨床診治